{"id":"https://openalex.org/W171808537","doi":null,"title":"Efficacy of Bydureon in Adults with Type 2 Diabetes","display_name":"Efficacy of Bydureon in Adults with Type 2 Diabetes","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W171808537","mag":"171808537"},"language":"en","primary_location":{"id":"pmh:oai:digitalcommons.unf.edu:etd-1525","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.unf.edu/cgi/viewcontent.cgi?article=1525&context=etd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401214","display_name":"University of North Florida Digital Commons (University of North Florida)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I11874761","host_organization_name":"University of North Florida","host_organization_lineage":["https://openalex.org/I11874761"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"UNF Graduate Theses and Dissertations","raw_type":"thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053283625","display_name":"Katie L. Fetter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Katie L. Fetter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5053283625"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9599999785423279},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9440000057220459},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9409999847412109},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9670000076293945},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9810000061988831},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7379999756813049},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.8320000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8585307598114014},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.8095542192459106},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6623849868774414},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.6488208174705505},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.5135335922241211},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4683033227920532},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4117193818092346},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4039720892906189},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3437301814556122},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3431108593940735},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.17100629210472107}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digitalcommons.unf.edu:etd-1525","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.unf.edu/cgi/viewcontent.cgi?article=1525&context=etd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401214","display_name":"University of North Florida Digital Commons (University of North Florida)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I11874761","host_organization_name":"University of North Florida","host_organization_lineage":["https://openalex.org/I11874761"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"UNF Graduate Theses and Dissertations","raw_type":"thesis"},{"id":"mag:171808537","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.unf.edu/cgi/viewcontent.cgi?article=1525&context=etd","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W2038305120","https://openalex.org/W2043900831","https://openalex.org/W2057002261","https://openalex.org/W2072691447","https://openalex.org/W2103132883","https://openalex.org/W2107949845","https://openalex.org/W2129934471","https://openalex.org/W2146901298","https://openalex.org/W2156472431","https://openalex.org/W2158216255","https://openalex.org/W2159561462","https://openalex.org/W2327349465","https://openalex.org/W2520432709"],"related_works":["https://openalex.org/W2463440353","https://openalex.org/W4256240469","https://openalex.org/W573150231","https://openalex.org/W1985874700","https://openalex.org/W1965434398","https://openalex.org/W2342564780","https://openalex.org/W195740977","https://openalex.org/W2437862739","https://openalex.org/W1922280217","https://openalex.org/W7099460088"],"abstract_inverted_index":{"Type":[0],"2":[1,41,53,139,163,274],"diabetes":[2,42,54,164,238],"is":[3,80],"still":[4],"rapidly":[5],"on":[6,76],"the":[7,15,19,29,36,72,77,123,227,256,261],"rise":[8],"today,":[9],"affecting":[10],"10.5%":[11],"of":[12,26,31,67,71,96,117,125,146,181,230,236],"individuals":[13],"in":[14,45,64,135,159,183,200],"United":[16],"States":[17],"between":[18,28,194],"ages":[20,30],"45":[21],"to":[22,33,89,106,113,121,196,225,232,246],"64":[23],"and":[24,155,167,208,240,267],"18.4%":[25],"those":[27],"65":[32],"74.":[34],"In":[35],"past":[37],"two":[38],"decades,":[39],"type":[40,52,138,162,273],"has":[43,92],"doubled":[44],"all":[46],"age":[47],"groups.":[48],"Many":[49],"adults":[50,136,160,271],"with":[51,137,161,243,272],"experience":[55],"difficulty":[56],"managing":[57],"their":[58,237,249],"blood":[59],"sugars,":[60],"which":[61,108],"can":[62],"result":[63],"a":[65,81,93,101,126,178,184,190],"range":[66],"further":[68],"complications.":[69],"One":[70],"newest":[73],"treatment":[74,257],"options":[75,258],"market":[78],"today":[79],"glucagon-like":[82],"peptide-1":[83],"(GLP-1)":[84],"receptor":[85,264],"agonist,":[86,265],"Bydureon.":[87,220],"Similar":[88],"Byetta,":[90],"Bydureon":[91,171,266],"main":[94],"ingredient":[95],"exenatide.":[97],"It":[98],"offers":[99],"once":[100,132],"week":[102],"dosing":[103],"as":[104],"opposed":[105],"twice-a-day,":[107],"may":[109],"be":[110,253],"more":[111],"appealing":[112],"patients.":[114],"The":[115],"purpose":[116],"this":[118],"study":[119,145],"was":[120,172],"examine":[122],"efficacy":[124,150,269],"newly":[127],"FDA":[128],"released":[129],"medication,":[130],"Bydureon,":[131],"weekly":[133],"dosage":[134],"diabetes.":[140,275],"A":[141],"descriptive,":[142],"comparative,":[143],"retrospective":[144],"35":[147],"patients":[148,218],"evaluated":[149],"by":[151,177],"examining":[152],"Hgb":[153,202],"A1C":[154,203],"body":[156],"mass":[157],"index":[158],"at":[165],"baseline":[166,195],"3":[168,197],"months":[169],"after":[170],"prescribed.":[173],"Data":[174],"were":[175],"collected":[176],"chart":[179],"review":[180],"records":[182],"primary":[185],"care":[186,222,231,239],"practice.":[187],"Results":[188],"demonstrated":[189],"statistically":[191],"significant":[192],"difference":[193],"month":[198],"means":[199],"both":[201],"(t":[204,210],"(34)=":[205],"-3.05,":[206],"p=.0044)":[207],"BMI":[209],"(34)":[211],"=":[212,215],"-2.86,":[213],"p":[214],".0072)":[216],"for":[217,270],"using":[219],"Health":[221],"providers":[223],"need":[224],"individualize":[226],"patients\u2019":[228],"plans":[229],"address":[233],"multifactorial":[234],"areas":[235],"provide":[241],"them":[242],"an":[244],"opportunity":[245],"successfully":[247],"meet":[248],"goals.":[250],"Practitioners":[251],"must":[252],"knowledgeable":[254],"about":[255],"available,":[259],"including":[260],"newer":[262],"GLP-1":[263],"its":[268]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}